Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1986-03-31
1988-12-06
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424 89, 435 2, 435238, 514802, A61K 3514, A61K 3912, A01N 102, C12N 706
Patent
active
047895454
ABSTRACT:
A method of removing lipid soluble process chemicals from biological materials containing the lipid soluble process chemicals comprising bringing the biological materials containing the lipid soluble process chemicals into contact with an effective amount of a naturally occurring oil extracted from a plant or an animal or a synthetic compound of similar chemical structure, agitating the resultant mixture, separating out an upper-phase and a lower-phase by sedimentation and decanting the upper-phase. The method is particularly useful for producing relatively virus free physiologically acceptable plasma.
REFERENCES:
patent: 3647624 (1972-03-01), Evenson
patent: 3682835 (1972-08-01), Louderback
patent: 4314997 (1982-02-01), Shanbrom
patent: 4481189 (1984-11-01), Prince
patent: 4522809 (1985-06-01), Adamowicz et al.
patent: 4534972 (1985-08-01), Lembach
patent: 4540573 (1985-09-01), Neurath
patent: 4615886 (1986-10-01), Purcell et al.
patent: 4647536 (1987-03-01), Mosbach et al.
Chemical Abstracts, vol. 96, No. 13, 29th Mar. 1982, p. 516, abstract no. 101990k, Columbus, Ohio, US; N. Shibata et al.: "Efficient elimination of lipid-soluable toxic substances by silicone oil hemodialysis", & Med. J. Osaka Univ. 1981, 32(1--2), 1-10.
Chemical Abstracts, vol. 77, No. 11, 11th Sep. 1972, pp. 234-235, abstract no. 7231w, Columbus, Ohio, US; M. A. Evenson et al.: "Direct-contact (membraneless) hemoperfusion through oils", & Clin. Chem. 1972, 18(6), 554-562.
F. W. Hartman, G. A. LoGrippo, "Combined beta-Propiolactone and Ultraviolet Irradiation for Plasma Sterilization", Hepatitis Frontiers, Henry Ford Hospital International Symposium, Brown & Co. (1957), 407-416.
D. Heinrich and H. Berthold, "Application of Cold Sterilized Prothrombin Complex Concentrates in Man, Clinical and Serological Studies", XIII International Congress of the World Federation of Hemophilia, Tel Aviv, Jul. 8-13, 1979.
R. Kotitschke, W. Stephen, "Kominierte Behandlung von Gerinnungsfaktoren in Humanplasma mit B-Propiolacton and UV. Struktur und Funktion des Fibrinogens", H. Schroeer, G. Hauck, F. Zimmerman et al, eds. Blutgerinnung und Mikrozirkulation Stuttgart: Verlag (1976), 222-228.
Von. N. Heimburger, H. Schwinn, P. Gratz et al, "Faktor VIII-Konzentrate, Hochgereinigt und in Losung Erhitzt, "Arzneim-Thromb/Drug Res. (1981), 31, 619.
N. Heimburger, H. Schwinn, R. Mauler, "Factor VIII Concentrate, Hepatitis-Safe: Progress in the Treatment of Hemophilia A", Die gelben Hefte (1980), 20, 165-174.
E. Tabor, D. L. Aronson, R. J. Gerety, "Removal of Hepatitis B Virus Infectivity from Factor IX Complex by Hepatitis B Immune Globulin", Lancet (1980), 2, 68-70.
H. G. J. Brummelhuis, J. Over, L. A. Duivis--Vorst et al, "Contributions to the Optimal Use of Human Blood. IX Elimination of Hepatitis B Transmission by (Potentially) Infectious Plasma Derivatives", Vox San (1983), 45, 205-216.
J. W. Oliphant, A Hollaender, "Homologous Serum Jaundice Experimental Inactivation of Etiologic Agent in Serum by Ultraviolet Irradiation", Public Health Rep. (1945), 61, 598-602.
F. O. MacCallum, "Homologous Serum Hepatitis", Proc. Roy. Soc. Med. (1946), 39, 655.
R. Murray, J. W. Oliphant, J. T. Tripp et al, "Effect of Ultraviolet Radiation on the Infectivity of Icterogenic Plasma, " JAMA (1955), 157, 8-14.
G. A. LoGrippo, H. Hayashi, "Efficacy of beta--Propiolactone with Ultra violet Irradiation of Hepatitis B Antigen in Human Plasma Pools", Henry Ford Hosp. Med. J. (1973), 21, 181-186.
D. Heinrich, H. Berthold, "Application of Cold Sterilized Prothrombin Complex Concentrates in Man: Clinical and Serological Studies", The 13th International Congress of the World Federation of Hemophilia, Tel Aviv, Jul. 8-13, 1979.
W. Stephen, A. M. Prince, "Efficacy of Combined Treatment of Factor IX Complex (PPSB) with .beta.-Propiolactone (b--PL) and Ultraviolet (UV) Irradiation", Haemostatis. (1981), 10, 67.
A. M. Prince, W. Stephan, B. Brotman, ".beta.-Propiolactone/Ultraviolet Irradiation: A Review of its Effectiveness for Inactivation of Viruses in Blood Derivatives", Rev. Infect. Dis. (1983), 5, 92-107.
W. Stephen, A. M. Prince and R. Kotitschke, "Factor VIII Concentrate from Cold Sterilized Human Plasma", Develop Biol. Stand (1983), 54, 491.
S. S. Gellis, J. R. Neefe, J. Stokes Jr. et al, "Chemical, Clinical and Immunological Studies on the Products of Human Plasma Fractionation XXXVI Inactivation of the Virus of Homologous Serum Hepatitis in Solutions of Normal Human Serum Albumin by Means of Heat", J. Clin. Invest. (1948), 27, 239-244.
R. Murray, W. C. L. Diefenbach, "Effect of Heat on the Agent of Homologous Serum Hepatitis", Proc. Soc. Exp. Biol. Med. (1953), 84, 230-231.
J. P. Soulier, C. Blatix, A. M. Courouce et al., "Prevention of Virus B Hepatitis (SH Hepatitis)", Am. J. Dis. Chid. (1972), 123, 429-434.
T. Shikata, T. Karasawa, K. Abe et al, "Incomplete Inactivation of Hepatitis B Virus After Heat--Treatment at 60.degree. C. for 10 hours", J. Infect. Dis. (1978), 138, 242-244.
E. Tabor, R. J. Gerety, "The Chimpanzee Animal Model for non-A non-B Hepatitis: New Applications", W. Szmuness, H. J. Alter, J. E. Maynard eds. Viral Hepatitis: 1981 International Symposium., Philadelphia: The Franklin Press (1981), 305-317.
E. Tabor, G. Murano, P. Snoy et al, "Inactivation of Hepatitis B Virus by Heat in Antithrombin III Stabilized with Citrate", Thromb Res. (1981), 22, 233-238.
D. Menache, D. L. Aronson, "Measures to Inactivate Viral Contaminants of Pooled Plasma Products", R. Y. Dodd, L. F. Baker eds. Infection Immunity and Blood Transfusion Proc. XVII Annual Scientific Symposium, May 9-11, 1984. New York, Alan R. Loss (1985), 407-423.
G. Dolana, D. Tse, W. Thomas et al, "Hepatitis Risk Reduction in Hemophilia: A Heated Factor VIII Preparation", J. Amer. Soc. Hematol. (1982), 60 (Supp 1), 2102.
F. R. Hollinger, G. Dolana, W. Thomas et al, "Reduction of Infectivity of Hepatitis B Virus (HBV) and a non-A, non-B Hepatitis Agent by Heat Treatment of Human Antihemophilic Factor (AHF) Concentrates", L. R. Overbyk F. Deinhardt, J. Deinhardt, eds., Viral Hepatitis: Second International Max von Pettenkofer Symposium, New York: Marcel Dekker, Inc. (1983) 245-246.
F. B. Hollinger, G. Dolana, W. Thomas et al, "Reduction in Risk of Hepatitis Transmission by Heat--Treatment of a Human Factor VIII Concentrate", J. Infect. Dis. (1984), 150, 250-262.
A. M. Prince, B. Horowitz, B. Brotman et al, "Inactivation of Hepatitis B and Hutchinson Strain non-A, non-B hepatitis Viruses by Exposure to Tween 80 and Ether", Vox Sang (1984), 46, 36-43.
S. M. Feinstone, K. B. Mihalik, T. Kamimura et al, "Inactivation of Hepatitis B Virus and non--A, non--B Hepatitis by Chloroform", Infect. Immunol. (1983), 41, 816-821.
D. W. Bradley, J. E. Maynard, H. Popper et al, "Posttransfusion non--A, non--B Hepatitis: Physiochemical Properties of Two Distinct Agents", J. Infect. Dis. (1983), 254-265.
A. M. Prince, B. Horowitz, B. Brotman et al, "Inactivation of Hepatitis B Virus and non-A, non-B hepatitis by Chloroform", Infect. Immunol. (1983), 41, 816-821.
M. Colombo, V. Carnelli, C. Gazengel, P. M. Mannucci, G. F. Savidge, K. Schimpf, "Transmission of non-A, non-B Hepatitis by Heat-Treated Factor VIII Concentrate", Lancet (1985), Jul. 1-4.
F. E. Preston, C. R. M. Hay, M. S. Dewar, M. Greaves, D. R. Triger, "Non-A, non-B, Hepatitis and Heat Treated Factor VIII Concentrates", Lancet (1985), Jul. 213.
C. Rouzioux, S. Chamaret, L. Montggnier, V. Carnelli, G. Rolland, P. M. Mannucci, "Absence of Antibodies to AIDS Virus in Haemophiliacs Treated with Heat-Treated Factor VIII Concentrate", Lancet (1985), Feb., 271-272.
P. B. A. Kernoff, E. J. Miller, G. F. Savidge, S. J. Machin, M. S. Dewar, F. E. Preston, "Wet Heating for Saafer Factor VIII Concentrate?", Lancet 1985, Sep., 271.
Y. K. Yip, R. H. L. Pang, J. O. Oppenheim, M. S. Nashbar, D. Henriksen, T. Zerebeckyj--Eckhardt, J. Vilcek, "Stimulation of Human Gamma Interferon Production by Diterpene Esters", Infect and Immun. (1981), 131-139.
B. D. Williamson, E. A. Carswell, B. Y. Rubin, J. S. Prendergast, H. J. Old, "Human Tumor Necrosis Factor
Orme Thomas W.
Woods Kenneth R.
Carson Nancy S.
Griffin Ronald W.
New York Blood Center Inc.
LandOfFree
Removal of lipid soluble process chemicals from biological mater does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Removal of lipid soluble process chemicals from biological mater, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Removal of lipid soluble process chemicals from biological mater will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1493286